Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-14 12:26 pm Unchanged | 13G | PALISADE BIO INC PALI | Altium Capital Management LP | 0 0% | 0 (Unchanged) | View |
| 2022-12-21 2:12 pm Purchase | 13G | ASTRIA THERAPEUTICS INC ATXS | Altium Capital Management LP | 1,355,372 5.2% | 1,355,372 (New Position) | View |
| 2022-11-17 5:08 pm Purchase | 13G | NEUROBO PHARMACEUTICALS INC CO NRBO | Altium Capital Management LP | 333,333 7.7% | 333,333 (New Position) | View |
| 2022-11-08 7:44 pm Purchase | 13G | HYRECAR INC HYRE | Altium Capital Management LP | 1,736,915 5.8% | 1,736,915 (New Position) | View |
| 2022-02-14 3:09 pm Sale | 13G | PALISADE BIO INC PALI | Altium Capital Management LP | 3,350,000 9.99% | -644,302 (-16.13%) | View |
| 2022-02-14 3:06 pm Purchase | 13G | QUOIN PHARMACEUTICALS LTD QNRX | Altium Capital Management LP | 4,276,252 4.99% | 3,037,823 (+245.30%) | View |
| 2022-02-14 2:37 pm Purchase | 13G | PALISADE BIO INC PALI | Altium Capital Management LP | 3,994,302 4.99% | 2,668,410 (+201.25%) | View |
| 2022-02-14 2:30 pm Sale | 13G | REGULUS THERAPEUTICS INC RGLS | Altium Capital Management LP | 1,729,780 2.1% | -1,500,000 (-46.44%) | View |
| 2022-02-14 10:16 am Unchanged | 13G | URBAN-GRO INC UGRO | Altium Capital Management LP | 0 0% | 0 (Unchanged) | View |
| 2022-02-14 09:53 am Unchanged | 13G | OCUPHIRE PHARMA INC OCUP | Altium Capital Management LP | 2,678,883 4.99% | 0 (Unchanged) | View |
| 2022-02-14 09:40 am Sale | 13G | TIMBER PHARMACEUTICALS, INC. TMBR | Altium Capital Management LP | 5,878,414 4.99% | -3,000,000 (-33.79%) | View |
| 2022-02-14 06:16 am Sale | 13G | ELECTROCORE INC ECOR | Altium Capital Management LP | 0 0% | -5,000,000 (Position Closed) | View |
| 2022-02-14 06:11 am Purchase | 13G | UNICYCIVE THERAPEUTICS INC UNCY | Altium Capital Management LP | 176,000 1.2% | 176,000 (New Position) | View |
| 2022-02-14 06:09 am Sale | 13G | INMUNE BIO INC ACCD INV INMB | Altium Capital Management LP | 0 0% | -909,091 (Position Closed) | View |
| 2022-02-14 06:07 am Unchanged | 13G | BIORESTORATIVE THERAPIES INC.C BRTX | Altium Capital Management LP | 200,000 4.99% | 0 (Unchanged) | View |
| 2022-02-14 06:05 am Sale | 13G | HEPION PHARMACEUTICALS INC HEPA | Altium Capital Management LP | 0 0% | -4,500,000 (Position Closed) | View |
| 2022-02-11 9:13 pm Sale | 13G | XTANT MED HLDGS INC XTNT | Altium Capital Management LP | 6,497,918 7.2% | -2,165,971 (-25.00%) | View |
| 2022-02-11 9:11 pm Unchanged | 13G | CREATIVE MED TECHNOLOGY HLDGS CELZ | Altium Capital Management LP | 363,000 4.99% | 0 (Unchanged) | View |
| 2022-02-11 9:07 pm Unchanged | 13G | SADOT GROUP INC SDOT | Altium Capital Management LP | 2,888,085 5% | 0 (Unchanged) | View |
| 2022-02-11 9:05 pm Purchase | 13G | RENOVACOR INC RCOR | Altium Capital Management LP | 731,561 4.99% | 731,561 (New Position) | View |